Liu Liping, Xu Yikai, Wu Yanni, Li Xiaoxia, Zhou Chunlan
Department of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Department of Nursing, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Front Psychol. 2021 Sep 3;12:654777. doi: 10.3389/fpsyg.2021.654777. eCollection 2021.
The Emotional Inhibition Scale (EIS) is a brief measure based on a four-factor model with documented validity in a mood disorder sample that may be useful for assessing emotional inhibition in patient populations, such as individuals with cancer. The present study adapted the EIS to Chinese conditions and examined the psychometric characteristics of the EIS in patients with cancer. The recruited participants comprised a sample of 100 patients (sample 1) and a sample of 202 patients (sample 2) with cancer. The two samples (sample 1 and sample 2) with cancer completed surveys including the EIS. The Toronto Alexithymia Scale-20 was completed by the two sample groups to assess criterion validity. Statistical analyses included internal consistency (sample 1), exploratory factor analyses (EFAs; sample 1), and confirmatory factor analyses (CFAs; sample 2). The results showed that EFA and CFA confirmed the four-factor solution proposed by the original authors (verbal inhibition, self-control, disguise of feelings, and timidity). The internal consistency and test-retest reliability of the EIS were satisfactory. In conclusion, the EIS demonstrated acceptable reliability and validity for assessing emotional inhibition in Chinese-speaking patients with cancer and may be a useful measure for assessing the level of emotional inhibition and the effect of emotional disclosure interventions.
情绪抑制量表（EIS）是一种基于四因素模型的简短测量工具，在情绪障碍样本中具有已被证实的效度，可能有助于评估患者群体（如癌症患者）的情绪抑制情况。本研究将EIS改编以适用于中国国情，并检验了EIS在癌症患者中的心理测量学特征。招募的参与者包括100名癌症患者样本（样本1）和202名癌症患者样本（样本2）。这两个癌症样本（样本1和样本2）完成了包括EIS在内的调查。两个样本组完成了多伦多述情障碍量表-20以评估效标效度。统计分析包括内部一致性分析（样本1）、探索性因素分析（EFA；样本1）和验证性因素分析（CFA；样本2）。结果表明，EFA和CFA证实了原作者提出的四因素结构（言语抑制、自我控制、情感伪装和胆怯）。EIS的内部一致性和重测信度令人满意。总之，EIS在评估华语癌症患者的情绪抑制方面显示出可接受的信度和效度，可能是评估情绪抑制水平和情绪表露干预效果的有用工具。
